Tatva Chintan Pharma Chem Limited

NSEI:TATVA Stock Report

Market Cap: ₹24.0b

Tatva Chintan Pharma Chem Balance Sheet Health

Financial Health criteria checks 6/6

Tatva Chintan Pharma Chem has a total shareholder equity of ₹7.4B and total debt of ₹142.7M, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are ₹8.2B and ₹816.4M respectively. Tatva Chintan Pharma Chem's EBIT is ₹332.1M making its interest coverage ratio 8.5. It has cash and short-term investments of ₹483.4M.

Key information

1.9%

Debt to equity ratio

₹142.71m

Debt

Interest coverage ratio8.5x
Cash₹483.43m
Equity₹7.37b
Total liabilities₹816.36m
Total assets₹8.19b

Recent financial health updates

No updates

Recent updates

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Sep 26
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

May 11
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Financial Position Analysis

Short Term Liabilities: TATVA's short term assets (₹3.0B) exceed its short term liabilities (₹796.6M).

Long Term Liabilities: TATVA's short term assets (₹3.0B) exceed its long term liabilities (₹19.7M).


Debt to Equity History and Analysis

Debt Level: TATVA has more cash than its total debt.

Reducing Debt: TATVA's debt to equity ratio has reduced from 90.3% to 1.9% over the past 5 years.

Debt Coverage: TATVA's debt is well covered by operating cash flow (687%).

Interest Coverage: TATVA's interest payments on its debt are well covered by EBIT (8.5x coverage).


Balance Sheet


Discover healthy companies